RWM
RVMD icon

Rialto Wealth Management’s Revolution Medicines RVMD Stock Holding History

Rialto Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3K Buy
16
+9
+129% +$1.31K ﹤0.01% 961
2026
Q1 		$681 Hold
7
– – ﹤0.01% 1254
2025
Q4 		$558 Buy
7
+2
+40% +$131 ﹤0.01% 1212
2025
Q3 		$234 Buy
5
+2
+67% +$78 ﹤0.01% 1464
2025
Q2 		$111 Buy
+3
New +$115 ﹤0.01% 1515

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Rialto Wealth Management's RVMD Position: Q2 2026 in Review

Rialto Wealth Management increased its Revolution Medicines (RVMD) stake by 129% in Q2 2026, buying an estimated $1.31K and bringing the position to 16 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #961.

Rialto Wealth Management first reported a position in RVMD in Q2 2025 and has held it in 5 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Rialto Wealth Management held 16 shares of Revolution Medicines worth $3K as of Q2 2026.
  • Rialto Wealth Management bought 9 Revolution Medicines shares in Q2 2026, an estimated $1.31K.
  • Revolution Medicines made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #961 holding.
  • Rialto Wealth Management first reported a position in Revolution Medicines in Q2 2025 and has held it in 5 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.